Cycad Group

People

Cycad Group
Paul F. Glenn
Chairman & Director
K. Leonard Judson
President & Managing Director
Robert J. Balch
Senior Vice President

In addition to being experienced venture capital investors, the backgrounds of Cycad Group’s investment team include substantial experience in entrepreneurial management, finance, law, marketing, and business development.


Paul F. Glenn

Paul F. Glenn is the Chairman and a Director of Cycad Group and was the driving force behind its creation. After spending several years on Wall Street, Paul left the investment banking firms and pursued a career of trading commodities and securities for his own account. His success in these areas led him to the world of private equity and venture capital where he became an early stage investor in a number of companies that have gone public or were acquired by public companies. He is a graduate of Princeton where he received a BA with high honors and also holds a J.D. from Harvard Law School.

In 1965 Paul also founded the Glenn Foundation for Medical Research, a 501(c)(3) non-profit foundation devoted to supporting basic research in the molecular biology of aging and age related diseases. The Foundation has been a leader in funding basic research in the science of aging for more than 40 years. Paul continues to serve as the Chairman and visionary for the Glenn Foundation.


K. Leonard Judson

K. Leonard Judson is the President and Managing Director of Cycad Group. Prior to co-founding Cycad Group in 2000, he practiced law for 14 years and was a partner in two law firms. Throughout his legal career a substantial portion of his practice was devoted to representing both companies and investors in corporate finance, mergers and acquisitions. Leonard’s entrepreneurial and management skills were further enhanced when he co-founded the law firm of May, Potenza, Judson and Baran, P.C. and served as its CEO until his departure to the Cycad Group. Leveraging upon his experience interning for the SEC while in law school and his subsequent securities law practice, Leonard was as a member of the NASD Board of Arbitrators from 1989 to 2002 and chaired a number of securities industry related arbitrations.

Among his activities at Cycad Group, Leonard serves as a Director or observer to the board of directors of several of Cycad Group’s portfolio companies including, ImaginAb, Nanosteel Corporation, Sofie Biosciences, and Lixivia. Leonard has previously been a director or board observer on the boards of Genocea Biosciences (Nasdaq NM: GNCA) and Clean Diesel Technologies, Inc. (Nasdaq NM: CDTI), GRT, Inc., ZT3 Technologies and Agile RF.

Leonard also serves as a Director and the Executive Vice President of the Glenn Foundation For Medical Research, Inc., a non-profit foundation supporting basic research to understand the biology of aging with the objective of developing interventions to extend the healthy years of human life.

Leonard holds a J.D. with Honors, from George Washington University, Washington, D.C., and a B.S. degree, Cum Laude, from Northern Arizona University.


Robert J. Balch

Robert J. Balch is a Senior Vice President of Cycad Group. Immediately prior to joining Cycad Group in 2004, Bob was a founding partner of Taraval Associates Seed Capital Fund; a venture fund specializing very early stage life sciences companies. As part of his activities with TASCF, Bob spent significant time working in Australia and New Zealand with entrepreneurs, government agencies and the venture capital communities (funding three companies and serving on the board of directors of one). Bob serves on the board of directors of SpectraFluidics, SteriFx, Agile RF and Iosil Energy and is a board observer at Iconix Video.

Bob brings extensive small business development and growth management experience to his venture capital activities. Early in his career Bob worked in sales and marketing in the pharmaceutical and medical device industries. He was also among the earliest employees in two healthcare startups: EndoTherapeutics (minimally invasive surgery) and Tokos Medical (perinatal monitoring). Bob then spent 11 years with Mark Products, Inc., a telecommunications company. He was the General Manager of Mark Products, with responsibility for all aspects the business when he left to form Taraval Associates Seed Capital Fund in 1997.

Bob holds a B.Sc. in Biological Sciences from California State University, Sacramento and an M.B.A. from the University of Phoenix.